Schedule 13G ownership disclosure
Bellerophon Therapeutics, Inc.
Security class unavailable · CUSIP: 078771102
Event date: 2018-08-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 962,415
- Percent of class
- 1.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-052673
- Form type
- SC 13G
- Filer
- Bellerophon Therapeutics, Inc.
- CIK
- CIK 1600132
- Filed
- Aug 20, 2018
- Reporting period
- Aug 13, 2018
- Description
- Schedule 13G beneficial ownership